Selected research
Market Structure
Global Sotalol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sotalol market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sotalol include Shaanxi Hanjiang Pharmaceutical Group, GSK, Bayer, Samarth Pharma Pvt. Ltd., Cipla Limited, Cambrex, Bristol-Myers Squibb (BMS), Arevipharma and Arbor Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sotalol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sotalol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sotalol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sotalol market size, projected growth trends, production technologies, key applications, and end-use industries.
Sotalol Segment by Company
Shaanxi Hanjiang Pharmaceutical Group
GSK
Bayer
Samarth Pharma Pvt. Ltd.
Cipla Limited
Cambrex
Bristol-Myers Squibb (BMS)
Arevipharma
Arbor Pharmaceuticals
Sotalol Segment by Type
40mg Sotalol
80mg Sotalol
Sotalol Segment by Application
Sustained Ventricular Tachycardia
Atrial Fibrillation/Flutter
Sotalol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotalol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sotalol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotalol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sotalol market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sotalol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sotalol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sotalol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg Sotalol
- 80mg Sotalol
Applications
- Sustained Ventricular Tachycardia
- Atrial Fibrillation/Flutter
Companies covered
- Shaanxi Hanjiang Pharmaceutical Group
- GSK
- Bayer
- Samarth Pharma Pvt. Ltd.
- Cipla Limited
- Cambrex
- Bristol-Myers Squibb (BMS)
- Arevipharma
- Arbor Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sotalol Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sotalol Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sotalol Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sotalol Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sotalol Market Dynamics
- 2.1 Sotalol Industry Trends
- 2.2 Sotalol Industry Drivers
- 2.3 Sotalol Industry Opportunities and Challenges
- 2.4 Sotalol Industry Restraints
3 Sotalol Market by Manufacturers
- 3.1 Global Sotalol Revenue by Manufacturers (2021-2026)
- 3.2 Global Sotalol Sales by Manufacturers (2021-2026)
- 3.3 Global Sotalol Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sotalol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sotalol Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sotalol Manufacturers, Product Type & Application
- 3.7 Global Sotalol Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sotalol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sotalol Players Market Share by Revenue in 2025
- 3.8.3 2025 Sotalol Tier 1, Tier 2, and Tier 3
4 Sotalol Market by Type
- 4.1 Sotalol Type Introduction
- 4.1.1 40mg Sotalol
- 4.1.2 80mg Sotalol
- 4.2 Global Sotalol Sales by Type
- 4.2.1 Global Sotalol Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sotalol Sales by Type (2021-2032)
- 4.2.3 Global Sotalol Sales Market Share by Type (2021-2032)
- 4.3 Global Sotalol Revenue by Type
- 4.3.1 Global Sotalol Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sotalol Revenue by Type (2021-2032)
- 4.3.3 Global Sotalol Revenue Market Share by Type (2021-2032)
5 Sotalol Market by Application
- 5.1 Sotalol Application Introduction
- 5.1.1 Sustained Ventricular Tachycardia
- 5.1.2 Atrial Fibrillation/Flutter
- 5.2 Global Sotalol Sales by Application
- 5.2.1 Global Sotalol Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sotalol Sales by Application (2021-2032)
- 5.2.3 Global Sotalol Sales Market Share by Application (2021-2032)
- 5.3 Global Sotalol Revenue by Application
- 5.3.1 Global Sotalol Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sotalol Revenue by Application (2021-2032)
- 5.3.3 Global Sotalol Revenue Market Share by Application (2021-2032)
6 Global Sotalol Sales by Region
- 6.1 Global Sotalol Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sotalol Sales by Region (2021-2032)
- 6.2.1 Global Sotalol Sales by Region (2021-2026)
- 6.2.2 Global Sotalol Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sotalol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sotalol Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sotalol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sotalol Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sotalol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sotalol Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sotalol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sotalol Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sotalol Revenue by Region
- 7.1 Global Sotalol Revenue by Region
- 7.1.1 Global Sotalol Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sotalol Revenue by Region (2021-2026)
- 7.1.3 Global Sotalol Revenue by Region (2027-2032)
- 7.1.4 Global Sotalol Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sotalol Revenue (2021-2032)
- 7.2.2 North America Sotalol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sotalol Revenue (2021-2032)
- 7.3.2 Europe Sotalol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sotalol Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sotalol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sotalol Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sotalol Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shaanxi Hanjiang Pharmaceutical Group
- 8.1.1 Shaanxi Hanjiang Pharmaceutical Group Company Information
- 8.1.2 Shaanxi Hanjiang Pharmaceutical Group Business Overview
- 8.1.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio
- 8.1.5 Shaanxi Hanjiang Pharmaceutical Group Recent Developments
- 8.2 GSK
- 8.2.1 GSK Company Information
- 8.2.2 GSK Business Overview
- 8.2.3 GSK Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 GSK Sotalol Product Portfolio
- 8.2.5 GSK Recent Developments
- 8.3 Bayer
- 8.3.1 Bayer Company Information
- 8.3.2 Bayer Business Overview
- 8.3.3 Bayer Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer Sotalol Product Portfolio
- 8.3.5 Bayer Recent Developments
- 8.4 Samarth Pharma Pvt. Ltd.
- 8.4.1 Samarth Pharma Pvt. Ltd. Company Information
- 8.4.2 Samarth Pharma Pvt. Ltd. Business Overview
- 8.4.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio
- 8.4.5 Samarth Pharma Pvt. Ltd. Recent Developments
- 8.5 Cipla Limited
- 8.5.1 Cipla Limited Company Information
- 8.5.2 Cipla Limited Business Overview
- 8.5.3 Cipla Limited Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Cipla Limited Sotalol Product Portfolio
- 8.5.5 Cipla Limited Recent Developments
- 8.6 Cambrex
- 8.6.1 Cambrex Company Information
- 8.6.2 Cambrex Business Overview
- 8.6.3 Cambrex Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Cambrex Sotalol Product Portfolio
- 8.6.5 Cambrex Recent Developments
- 8.7 Bristol-Myers Squibb (BMS)
- 8.7.1 Bristol-Myers Squibb (BMS) Company Information
- 8.7.2 Bristol-Myers Squibb (BMS) Business Overview
- 8.7.3 Bristol-Myers Squibb (BMS) Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bristol-Myers Squibb (BMS) Sotalol Product Portfolio
- 8.7.5 Bristol-Myers Squibb (BMS) Recent Developments
- 8.8 Arevipharma
- 8.8.1 Arevipharma Company Information
- 8.8.2 Arevipharma Business Overview
- 8.8.3 Arevipharma Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Arevipharma Sotalol Product Portfolio
- 8.8.5 Arevipharma Recent Developments
- 8.9 Arbor Pharmaceuticals
- 8.9.1 Arbor Pharmaceuticals Company Information
- 8.9.2 Arbor Pharmaceuticals Business Overview
- 8.9.3 Arbor Pharmaceuticals Sotalol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Arbor Pharmaceuticals Sotalol Product Portfolio
- 8.9.5 Arbor Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sotalol Value Chain Analysis
- 9.1.1 Sotalol Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sotalol Production Mode & Process
- 9.2 Sotalol Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sotalol Distributors
- 9.2.3 Sotalol Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst